全文获取类型
收费全文 | 1675篇 |
免费 | 133篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 72篇 |
妇产科学 | 82篇 |
基础医学 | 167篇 |
口腔科学 | 55篇 |
临床医学 | 153篇 |
内科学 | 283篇 |
皮肤病学 | 17篇 |
神经病学 | 105篇 |
特种医学 | 264篇 |
外科学 | 101篇 |
综合类 | 19篇 |
预防医学 | 80篇 |
眼科学 | 7篇 |
药学 | 178篇 |
肿瘤学 | 240篇 |
出版年
2021年 | 12篇 |
2020年 | 15篇 |
2019年 | 16篇 |
2018年 | 31篇 |
2017年 | 18篇 |
2016年 | 19篇 |
2015年 | 27篇 |
2014年 | 37篇 |
2013年 | 25篇 |
2012年 | 38篇 |
2011年 | 51篇 |
2010年 | 51篇 |
2009年 | 36篇 |
2008年 | 34篇 |
2007年 | 65篇 |
2006年 | 53篇 |
2005年 | 42篇 |
2004年 | 45篇 |
2003年 | 54篇 |
2002年 | 41篇 |
2001年 | 60篇 |
2000年 | 43篇 |
1999年 | 44篇 |
1998年 | 67篇 |
1997年 | 80篇 |
1996年 | 87篇 |
1995年 | 53篇 |
1994年 | 47篇 |
1993年 | 48篇 |
1992年 | 47篇 |
1991年 | 40篇 |
1990年 | 54篇 |
1989年 | 72篇 |
1988年 | 59篇 |
1987年 | 49篇 |
1986年 | 47篇 |
1985年 | 45篇 |
1984年 | 25篇 |
1983年 | 19篇 |
1982年 | 17篇 |
1981年 | 16篇 |
1980年 | 21篇 |
1979年 | 5篇 |
1978年 | 6篇 |
1977年 | 17篇 |
1976年 | 13篇 |
1975年 | 8篇 |
1974年 | 7篇 |
1971年 | 4篇 |
1966年 | 4篇 |
排序方式: 共有1836条查询结果,搜索用时 46 毫秒
1.
Isolated patellofemoral arthritis is an increasingly recognized entity, and is usually associated with previous patellofemoral dysplasia or instability. Patellofemoral arthroplasty (PFA) has evolved significantly in recent years, both in terms of implant design and importantly in the understanding of appropriate patient selection. This review outlines the indications and investigations for PFA, provides a brief history of the development of contemporary implants, and presents the clinical outcomes for the prostheses most commonly used in the UK. In addition, it provides a detailed surgical technique for implantation of an onlay implant, with tips on how to optimize patellofemoral biomechanics and thus achieve a consistently good outcome. 相似文献
2.
M Engelhardt P Bast N Jeblink W Lauer A Popovic H Eufinger M Scholz A Christmann A Harders K Radermacher K Schmieder 《Minimally invasive neurosurgery》2006,49(2):98-103
This study was performed to evaluate the surgical strategy in patients with calvarial tumours, in order to design and modify a robot-assisted trepanation system. A total of 75 patients underwent craniectomy for the treatment of calvarial tumours during the 10-year period from 1993 to 2002. The patients' complaints, the size, location and histology of the tumour, and the various cranioplasty techniques used were analysed retrospectively. In a second procedure several craniectomies at typical locations according to the study's results were performed in a laboratory setting using a hexapod robotic tool, constructed at the Helmholtz-Institute, RWTH Aachen University, and plastic model heads. The workflow was documented and the reproducibility and the accuracy of the procedure were registered. A total of 83 surgical procedures were performed on 75 patients. The majority (87 %) of lesions treated surgically were located in the frontal, temporal and anterior parts of the parietal region. Histological examination revealed benign lesions in 66 % of the patients and dural involvement in 46 %. According to these results craniectomies were performed using the robotic system. Mean positioning accuracy of the robotic system while milling was 0.24 mm, with a standard deviation of 0.04 mm, and maximum error under 1 mm. Craniectomies leaving a 1-mm layer of the tabula interna intact to ensure a healthy dura were performed in several regions successfully. The majority of calvarial tumours, requiring surgical treatment in our patients, were located in cosmetically relevant areas in which drilling can be carried out with the robotic trepanation system. Consequently, the surgical approach had to be planned carefully in order to achieve a good cosmetic outcome. 相似文献
3.
4.
Sonoelasticity imaging of prostate cancer: in vitro results 总被引:2,自引:0,他引:2
5.
6.
7.
Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma 总被引:9,自引:3,他引:6
Weisenburger DD; Gordon BG; Vose JM; Bast MA; Chan WC; Greiner TC; Anderson JR; Sanger WG 《Blood》1996,87(9):3860-3868
Primary CD30(Ki-1)-positive anaplastic large-cell lymphoma (ALCL) is considered by some to be a distinct clinicopathologic entity associated with the t(2;5) (p23;q35). However, the specificity of t(2;5) for ALCL has not been carefully studied. Therefore, we performed a detailed analysis of all cases of ALCL with abnormal cytogenetics results in the Nebraska Lymphoma Study Group registry, as well as all other cases of non-Hodgkin's lymphoma with t(2;5) in the registry. We found the t(2;5) in only five of 10 cases of ALCL, four of whom were young patients. However, we also found the t(2;5) in 11 other cases of nonanaplastic lymphoma, including eight children with typical peripheral T-cell lymphomas of various types. The t(2;5) was also found in three older adults with B-cell lymphomas of various types. Thus, the t(2;5) was not specific for CD30+ ALCL. However, t(2;5) may define a clinicopathologic entity in children and young adults characterized by variable morphologies with a T-cell or indeterminate phenotype, CD30-positivity, nodal disease with frequent extranodal involvement, advanced stage, and an excellent response to therapy, including bone marrow transplantation for relapsed disease. The clinical relevance of the t(2;5) in older patients requires further study. 相似文献
8.
9.
10.
BACKGROUND. Although the ascites of patients with ovarian cancer has been reported to contain immunosuppressive factors, the identity and source of this activity has not been determined. Previously, the authors showed that conditioned media from two of four epithelial ovarian cancer cell lines inhibits proliferation of mitogen-stimulated human lymphocytes. The physical characteristics of the inhibitory substance are unlike those of peptide growth factors but closely resemble those of fibronectin. METHODS AND RESULTS. In the current study, it was found that the two ovarian cancer cell lines that produce the inhibitory substance have more fibronectin on the cell surface and secrete significantly more immunoreactive fibronectin into their culture media than the other two ovarian cancer cell lines. In addition, the immunosuppressive activity was bound to a gelatin-Sepharose affinity column, known to bind fibronectin. Finally, in ascites from 20 patients with advanced epithelial ovarian cancer, fibronectin levels correlated with the ability to inhibit proliferation of lectin-stimulated lymphocytes (P < 0.001). CONCLUSIONS. Fibronectin is produced by some ovarian cancer cell lines and acts to inhibit proliferation of mitogen-stimulated lymphocytes. Additional studies are needed to clarify the role of fibronectin in ovarian cancer. 相似文献